Benign neoplasm: Brain, infratentorial

CD2_BENIGN_BRAIN_INFRATENT

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D33.1 Cause of death: ICD-10 — D33.1 2 out of 7 registries used, show all original rules.	208
4. Check minimum number of events None	208
5. Include endpoints None	208
6. Filter based on genotype QC (FinnGen only)	208

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D33
Name in latin: Neoplasma benignum cerebri infratentoriale

NAME	CD2_BENIGN_BRAIN_INFRATENT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D331
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D331
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Brain, infratentorial based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Brain, infratentorial

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1554	828	719
Only index persons	1386	743	643
Unadjusted period prevalence (%)
Whole population	0.02	0.02	0.02
Only index persons	0.03	0.03	0.02
Median age at first event (years)
Whole population	44.15	46.77	40.95
Only index persons	43.19	45.75	40.23

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	208	126	82
Unadjusted period prevalence (%)	0.04	0.04	0.04
Median age at first event (years)	47.97	46.83	49.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
185: Matched controls
1851

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

700.4

111.0

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

32.9

76.2

106

D33.10

ICD-10 Finland

Benign pilosytic astrocytoma of brain stem

+∞

64.4

D33.14

ICD-10 Finland

Hemangioblastoma and cerebellum

+∞

55.0

9161/1-C71.6

ICD-O-3

Hemangioblastoma of cerebellum, NOS

+∞

41.2

D33.15

ICD-10 Finland

Another benign tumor of the cerebellum

+∞

40.1

D33.11

ICD-10 Finland

Brain stem

+∞

36.7

D33.12

ICD-10 Finland

Cerebellum

+∞

32.2

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

+∞

28.9

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

27.0

28.4

C71.60

ICD-10 Finland

Malignant tumor of cerebellum without histology

+∞

27.8

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

47.8

26.8

D33.1

ICD-10 Finland

Benign neoplasm: Brain, infratentorial

+∞

21.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

9.0

21.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

5.6

19.4

163

9421/1-C71.6

ICD-O-3

Pilocytic astrocytoma of cerebellum, NOS

+∞

18.0

G91.1

ICD-10 Finland

Obstructive hydrocephalus

99.1

16.9

H02AB02

ATC

dexamethasone; systemic

5.8

14.9

AA1AD

NOMESCO Finland

CT of head and brain

3.8

13.6

262

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

13.0

12.7

D33.17

ICD-10 Finland

Fourth ventricle

+∞

12.6

R51.80

ICD-10 Finland

Headache

4.0

12.1

172

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

69.4

11.8

H53.2

ICD-10 Finland

Diplopia

11.7

11.6

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

21.7

11.3

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.7

10.9

187

ZXE20

NOMESCO Finland

More than three and less than five hours

3.9

10.5

143

AAF00

NOMESCO Finland

Ventriculostomy

42.5

10.1

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

42.5

10.1

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

18.0

10.1

ZXD05

NOMESCO Finland

Urgent procedure

2.9

9.8

366

XA800

NOMESCO Finland

Neuropsychological investigation

6.1

9.6

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

105.1

9.5

D33.42

ICD-10 Finland

Hemangioblastoma of the spinal cord

+∞

9.4

WX408

NOMESCO Finland

General anesthesy, balanced

2.9

9.4

333

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

94.1

8.5

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

94.1

8.5

Q85.82

ICD-10 Finland

of Hipple-Lindau syndrome

+∞

8.4

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

15.4

8.3

XCK00

NOMESCO Finland

Perimetry

4.9

7.8

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

46.9

7.8

G91.0

ICD-10 Finland

Communicating hydrocephalus

46.9

7.8

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

46.9

7.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.7

7.4

268

D32.05

ICD-10 Finland

Cerebral meninges

+∞

7.3

ZXD35

NOMESCO Finland

Usual procedure

8.3

6.7

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

23.5

6.7

N03AF01

ATC

carbamazepine; oral, rectal

7.3

6.7

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

15.0

6.5

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

72.2

6.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

11.6

6.4

C71.69

ICD-10 Finland

Malignant tumor of the cerebellum other or unspecified histology

+∞

6.3

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

+∞

6.3

G93.0

ICD-10 Finland

Cerebral cysts

+∞

6.3

AAF50

NOMESCO Finland

Third ventriculostomy

+∞

6.3

N76

ICPC

Neoplasm nervous system unspecified

+∞

6.3

C71.6

ICD-10 Finland

Malignant neoplasm: Cerebellum

+∞

6.3

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

27.7

6.3

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

6.2

450

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

13.1

6.2

R4110

NOMESCO Finland

Physiotherapy

2.4

6.1

318

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

6.0

473

Z2445

NOMESCO Finland

Psychologist

4.5

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

33.54

43.93

2.2

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

12.91

19.87

3.3

1.2

—

(3003396) Base excess in Arterial blood by calculation

167

4.02

15.71

7.1

11.3

mmol/l

0.7

1.4

0.72

137

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

14.94

15.18

2.8

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

11.47

12.99

2.8

3.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

8.73

12.94

4.2

3.7

nmol/l

1.4

3.3

1.45

(3044290) Cell count panel - Cerebral spinal fluid

6.56

12.39

2.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

126

741

2.78

11.59

7.3

7.6

mmol/l

1.2

1.77

118

675

(3044640) Blood type and Crossmatch panel - Blood

522

2.61

10.34

2.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

129

807

2.58

9.87

5.7

8.4

mmol/l

1.2

1.37

116

695

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

134

3.35

9.43

5.7

10.1

mmol/l

24.0

25.0

1.31

134

(3013826) Glucose [Moles/volume] in Serum or Plasma

147

1004

2.58

8.94

6.1

5.6

mmol/l

6.4

6.6

0.41

142

919

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

4.92

8.80

2.3

2.2

e6/l

24.3

3.4

0.61

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

4.92

8.80

2.5

2.3

e6/l

95.7

289.2

0.59

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

402

2.45

8.41

2.6

2.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

6.18

7.96

4.1

1.6

—

(4035726)

148

3.01

7.94

1.4

—

(3000991) Gas panel - Venous blood

151

2.86

7.10

5.4

10.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.46

6.82

4.3

15.8

—

(40768804) Tissue Pathology biopsy report

105

688

2.06

6.14

2.4

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

115

781

2.06

6.07

3.7

4.3

—

(3023410) Appearance of Cerebral spinal fluid

5.75

5.87

2.9

3.6

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

11.59

5.86

2.2

5.0

nmol/l

58.7

107.1

—

(3032080) INR in Blood by Coagulation assay

626

2.03

5.83

4.6

7.0

inr

1.2

0.06

195

(3014576) Chloride [Moles/volume] in Serum or Plasma

198

2.33

5.09

6.7

8.5

mmol/l

105.0

104.0

0.81

191

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

4.72

4.35

3.9

1.6

nmol/l

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

687

1.77

3.96

4.0

5.5

g/l

36.6

35.9

0.67

650

(3026008) Bacteria identified in Urine by Culture

502

1.77

3.65

3.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

608

1.64

2.95

2.9

3.7

ng/l

17.8

35.0

1.56

392

(3019309) Folate [Moles/volume] in Red Blood Cells

291

1.79

2.91

1.9

1.6

nmol/l

942.2

1207.1

1.12

219

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

428

1.68

2.81

2.0

2.2

mg/l

3.3

3.0

0.38

375

(3007853) Bacteria identified in Skin by Aerobe culture

196

1.88

2.63

1.5

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

141

1184

1.59

2.50

4.8

4.2

—

(3018095) Leukocytes [#/volume] in Urine

613

1.53

2.23

4.1

3.7

e6/l

40.2

64.0

0.62

426

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

110

888

1.51

2.23

5.7

7.0

umol/l

10.4

12.3

1.15

101

842

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.66

2.22

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

185

1.79

2.16

5.4

6.8

—

(3018418) pH of Serum or Plasma

491

1.54

2.12

2.9

4.2

7.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

611

1.50

2.08

3.4

3.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.09

2.08

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.58

2.07

1.7

1.5

ug/l

2.3

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

566

1.51

2.07

3.8

3.5

mmol/l

2.4

0.13

491

(1761868) Lipid panel - Serum or Plasma

603

0.62

2.04

2.1

2.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.63

1.95

1.4

1.2

—

(3013512) EKG study

429

1.52

1.92

2.8

3.7

—

(3019225) pH of Specimen

145

1.82

1.92

3.7

4.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

293

1.59

1.85

2.9

2.8

mmol/l

2.4

2.03

251

(3020891) Body temperature

2.24

1.82

13.0

4.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

295

1.58

1.80

3.1

2.8

e6/l

0.7

1.0

0.40

162

(3023368) Bacteria identified in Blood by Culture

427

1.50

1.77

3.2

4.3

—

(36304419) Bacteria [Presence] in Urine

482

1.44

1.57

3.6

2.9

—

(4010399)

126

0.38

1.56

1.2

1.4

—

(21494755) Public health laboratory ask at order entry panel

202

0.47

1.56

1.8

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

493

1.43

1.53

3.6

3.0

e6/l

0.2

0.3

0.54

362

(3002582) Erythrocytes [#/volume] in Urine

531

1.42

1.51

3.5

3.1

e6/l

26.0

162.1

0.57

403

(40761536) Microorganisms panel - Urine sediment

152

0.44

1.50

3.1

3.5

—

(40761535) Cells panel - Urine sediment

126

1.74

1.46

2.8

3.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1.96

1.43

1.6

mu/l

263.4

341.9

0.64

(3012095) Magnesium [Moles/volume] in Serum or Plasma

277

1.50

1.40

1.9

5.5

mmol/l

0.8

0.08

262

(3027945) Reticulocytes/100 erythrocytes in Blood

176

1.61

1.40

1.4

4.4

2.0

1.7

0.64

163

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

269

1.50

1.39

3.5

3.0

e6/l

2.9

2.5

0.08

138

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

516

1.38

1.29

2.0

2.6

u/l

52.3

54.0

0.22

483

(3052851) Hemolysis interference index of Serum or Plasma

2.09

1.28

2.2

3.5

—

(3019060) Gas panel - Arterial blood

100

1.76

1.28

9.8

8.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

631

1.35

1.25

2.3

1.9

pmol/l

98.5

97.0

0.09

306

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

147

1329

1.36

1.21

4.3

3.9

pmol/l

14.6

14.7

0.12

134

1198

(3001122) Ferritin [Mass/volume] in Serum or Plasma

797

1.33

1.21

2.5

2.8

ug/l

129.8

97.8

0.57

737

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

113

1.65

1.10

3.6

3.1

ml/min/173m2

72.8

67.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

169

1572

1.40

1.09

13.4

12.2

ml/min/173m2

89.0

85.3

1.42

146

1266

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

2.16

1.06

1.0

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

250

1.43

1.04

1.5

1.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

723

1.30

1.03

2.6

2.5

nmol/l

73.9

76.3

0.32

646

(3043409) Potassium [Moles/volume] in Arterial blood

1.87

1.00

12.9

3.9

mmol/l

3.7

3.8

—

(3049717) Cytology report of Urine Cyto stain

1.84

0.98

2.4

2.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

176

1.48

0.96

1.5

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.92

0.95

1.3

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

184

1749

1.45

0.93

16.7

13.6

mg/l

21.5

21.7

0.04

162

1373

(3027008) Opiates [Presence] in Urine

102

0.48

0.92

3.4

1.8

—

(3028300) Cannabinoids [Presence] in Urine

102

0.48

0.92

3.4

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

103

0.47

0.92

3.4

1.8

—

(3027944) Amphetamines [Presence] in Urine

104

0.47

0.91

1.6

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

157

1668

0.76

0.89

4.8

4.6

mmol/l

2.8

0.49

145

1539

(3042936) Bacteria identified in Isolate by Culture

240

1.39

0.89

2.2

2.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.03

0.87

2.3

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.79

0.85

1.4

1.6

—

(42870588) Differential panel, method unspecified - Blood

594

1.27

0.84

4.4

6.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

163

0.59

0.82

1.2

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

155

1643

0.78

0.80

4.2

mmol/l

4.7

0.57

142

1530

(3016879) Cocaine [Presence] in Urine

0.50

0.80

3.2

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

255

1.35

0.78

2.8

2.9

ug/l

1.0

0.8

0.82

163

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.78

0.0

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

168

1587

1.30

0.77

5.3

4.6

mu/l

1.7

2.6

0.66

155

1446

(3020630) Protein [Mass/volume] in Serum or Plasma

133

0.59

0.76

1.3

3.6

g/l

64.8

66.6

—

125

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

329

1.31

0.76

1.7

pmol/l

447.2

483.1

0.37

284

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

203

1.38

0.75

4.0

4.3

31.2

32.3

0.23

131

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

154

1630

0.79

0.75

4.2

mmol/l

1.5

0.04

142

1507

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

113

1234

0.82

0.73

3.1

3.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.82

0.73

1.1

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

392

0.75

0.72

1.8

2.1

mg/l

0.7

1.2

1.93

308

(3026782) Osmolality of Urine

341

1.29

0.71

2.3

2.7

mosm/kgh2o

503.0

555.3

0.86

290

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

179

1.39

0.71

1.5

1.8

—

(3012544) pH of Venous blood

179

1.39

0.71

3.6

6.6

—

(3023520) Reticulocytes [#/volume] in Blood

127

1.46

0.70

1.6

4.0

e9/l

64.8

73.5

0.45

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

141

1311

1.23

0.70

7.1

7.4

u/l

77.2

81.4

0.67

133

1218

(3025130) Human papilloma virus identified in Specimen

1.80

0.66

1.4

1.9

—

(3019150) Specific gravity of Urine by Refractometry

383

1.26

0.65

3.6

3.9

kg/l

1.0

0.04

(40768797) Stomach Pathology biopsy report

218

1.33

0.64

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

105

1.46

0.62

1.2

—

(3024928) Oxygen saturation in Venous blood

1.68

0.62

1.0

10.9

—

(40761511) CBC panel - Blood by Automated count

188

1817

1.36

0.61

14.4

11.9

—

(3017181) Myelocytes/100 leukocytes in Blood

150

0.65

0.60

2.7

4.4

2.2

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.60

0.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

341

1.25

0.58

3.8

4.6

22.0

21.2

0.16

158

(40760892) CBC W Ordered Manual Differential panel - Blood

413

0.79

0.58

4.2

4.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.49

0.55

1.8

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.50

0.54

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.50

0.54

1.0

1.1

—

(3001604) Monocytes [#/volume] in Blood

100

920

1.17

0.49

4.9

6.6

e9/l

0.6

0.11

802

(3019198) Lymphocytes [#/volume] in Blood

103

950

1.17

0.49

4.9

6.6

e9/l

1.8

1.9

0.47

855

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.41

0.45

1.0

2.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

168

1618

1.20

0.44

17.2

15.0

40.0

0.03

124

1257

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.45

0.43

2.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.58

0.42

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.58

0.42

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.58

0.42

1.2

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

418

0.83

0.42

1.9

2.9

umol/l

316.9

8038.0

2.24

358

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(4146454)

0.00

0.41

0.0

3.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.7

—

3.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.41

0.0

4.2

—

(3044941) Cell count panel - Synovial fluid

0.00

0.41

0.0

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.41

0.0

2.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.41

0.0

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

14.1

—

1362.6

—

(3006315) Basophils [#/volume] in Blood

920

1.15

0.41

4.9

6.6

e9/l

0.0

0.33

803

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.35

0.41

1.9

2.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

105

0.66

0.40

1.1

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.3

—

5.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.39

0.0

3.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.3

—

3.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

292

1.20

0.38

3.6

3.7

ng/l

43.6

133.6

1.23

224

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

318

0.83

0.36

1.5

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.35

0.36

3.7

2.3

—

(3011288) Drugs identified in Urine by Screen method

0.65

0.36

4.4

2.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

123

0.72

0.36

1.1

1.4

—

(3036489) Thrombin time

0.63

0.36

1.0

3.9

20.4

22.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

907

1.13

0.35

4.7

6.8

27.5

29.3

0.74

854

(3044889) 12 lead EKG panel

120

1137

1.13

0.35

3.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

113

1191

0.89

0.34

3.7

3.2

u/l

50.2

43.2

0.43

105

1127

(3009508) Creatinine [Moles/volume] in Urine

503

0.87

0.34

2.6

3.3

mmol/l

7.9

7.6

0.12

421

(3013115) Eosinophils [#/volume] in Blood

100

941

1.12

0.32

4.9

7.1

e9/l

0.2

0.27

842

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.72

0.31

1.9

1.4

—

(3003694) ABO and Rh group [Type] in Blood

500

1.14

0.31

1.5

—

(3022313) Gas panel - Capillary blood

111

1.28

0.31

4.4

5.0

—

(3002256) Pathology report gross observation

195

1.20

0.30

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

107

0.74

0.30

1.4

2.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

237

0.83

0.29

1.9

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

139

0.78

0.28

3.8

2.5

g/l

8.8

10.0

0.85

129

(3045414) Leukocytes [Presence] in Urine

1.24

0.27

2.1

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

389

1.13

0.26

4.1

3.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.26

0.26

1.3

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

846

1.09

0.22

3.8

3.6

estimate

0.0

0.00

172

(3012441) Differential panel - Pleural fluid

0.00

0.21

0.0

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

1.0

—

119.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

3.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.21

0.0

2.4

—

139.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

685.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.21

0.0

3.8

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.21

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.21

0.0

1.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.21

0.0

2.9

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

156.4

—

(3000492) Spirometry study

166

0.83

0.21

1.1

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

298

1.13

0.21

1.3

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

405

0.89

0.21

1.2

1.4

g/l

2.3

2.1

0.22

245

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.21

0.0

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

0.00

0.21

0.0

1.2

—

52733.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.21

0.0

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.21

0.0

2.7

—

32.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.20

0.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.20

0.0

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.20

0.0

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

445

0.90

0.20

3.1

4.0

mg/mmol

2.0

8.6

3.63

278

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.18

0.19

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

137

1.18

0.19

3.9

4.5

mmol/l

2.4

1.4

0.43

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

164

0.84

0.19

1.9

1.8

—

(3022145) Colonoscopy Study observation

185

1.15

0.19

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.21

0.18

1.1

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

119

1.19

0.18

1.2

1.5

—

(36660697) Celiac disease serology panel - Serum

157

1.16

0.18

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.17

0.18

1.0

1.2

—

(3000494) Fungus identified in Specimen by Culture

215

0.87

0.17

1.2

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

154

1573

0.92

0.17

3.7

3.8

mmol/l

1.3

0.11

141

1450

(40768443) Skin Pathology biopsy report

0.77

0.16

1.2

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

131

1276

1.07

0.16

3.9

4.0

mm/h

11.4

10.8

0.17

120

1166

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.81

0.15

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

0.82

0.15

3.1

3.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.79

0.15

1.3

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.19

0.15

1.6

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

149

0.86

0.14

2.4

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

151

1.14

0.14

3.1

3.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

497

0.93

0.13

3.2

3.1

—

(40758558) Short blood count panel - Blood

465

1.07

0.12

5.6

8.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

143

1.13

0.12

1.3

1.5

—

(3009343) pH of Capillary blood

143

1.13

0.12

4.1

4.4

—

7.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

125

0.87

0.10

3.5

2.5

—

15.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

401

0.94

0.10

1.8

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1.11

0.10

1.0

—

10.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

183

1847

0.92

0.09

10.0

10.1

u/l

25.8

25.7

0.04

176

1785

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

420

1.06

0.09

2.1

3.6

ng/l

436.7

1239.3

2.62

354

(3013650) Neutrophils [#/volume] in Blood by Automated count

109

1067

1.05

0.09

7.2

10.3

e9/l

4.2

4.0

0.44

937

(3023511) Choriogonadotropin [Units/volume] in Urine

1.04

0.08

1.0

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.04

0.08

1.0

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

150

1520

0.95

0.08

5.5

5.3

mmol/mol

37.3

39.3

2.53

140

1427

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.82

0.08

1.6

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.83

0.08

1.8

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1.08

0.08

8.3

9.5

mg/l

1.1

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.06

0.08

1.7

1.5

—

(3021589) Normoblasts [#/volume] in Blood

820

0.96

0.07

6.3

10.3

e9/l

0.0

0.53

656

(3028626) Oxygen [Partial pressure] in Capillary blood

0.85

0.07

5.3

4.9

kpa

10.2

8.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

294

0.94

0.06

2.5

2.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

237

1.06

0.06

1.4

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

853

1.03

0.06

5.7

4.9

estimate

0.0

0.00

173

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

287

1.05

0.05

1.3

iu/ml

11.5

30.9

—

102

(3012516) Albumin [Mass/volume] in Urine

424

0.96

0.05

2.4

3.2

mg/l

21.3

360.6

0.94

268

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

270

0.96

0.03

2.3

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

471

0.97

0.03

3.8

3.9

estimate

0.0

—

168

(3037522) Nuclear Ab [Titer] in Serum

221

1.05

0.03

1.2

1.4

titre

208.0

494.0

—

(3003338) MCHC [Mass/volume]

152

1512

1.02

0.01

22.5

17.9

g/l

333.2

332.6

0.39

152

1505

(3019832) Treponema pallidum Ab [Presence] in Serum

213

1.04

0.01

1.4

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

373

1.02

0.01

1.8

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

124

1.05

0.00

2.0

1.8

—

(3010813) Leukocytes [#/volume] in Blood

195

1949

1.01

0.00

24.3

19.9

e9/l

6.9

6.6

1.24

189

1894

(3026361) Erythrocytes [#/volume] in Blood

195

1949

1.01

0.00

24.3

19.9

e12/l

4.5

0.03

189

1895

(3009261) Glucose [Presence] in Urine by Test strip

864

0.99

0.00

4.2

3.7

estimate

0.0

0.00

168

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

669

1.00

0.00

3.9

3.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

113

0.97

0.00

1.8

1.3

—

24.9

—

(3022621) pH of Urine by Test strip

127

1.03

0.00

3.9

2.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

162

1617

1.01

0.00

4.4

4.2

mmol/l

5.6

5.9

2.30

150

1477

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

438

1.01

0.00

1.2

1.3

u/ml

5.6

1.2

0.48

118

(3007461) Platelets [#/volume] in Blood

195

1948

1.02

0.00

24.3

19.9

e9/l

261.3

252.1

1.26

189

1898

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

278

1.01

0.00

1.4

1.3

u/ml

9.4

8.3

0.05

116

(3004716) Salmonella sp identified in Stool by Organism specific culture

105

0.95

0.00

1.0

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

3.0

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.0

2.8

—

(3004451) EKG impression Narrative

0.00

0.0

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.0

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.02

0.00

1.2

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.0

1.3

—

(3024263) Appearance of Synovial fluid

0.00

0.0

1.4

—

(3024471) HLA-A [Type]

0.00

0.0

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.0

1.4

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.8

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.0

33.2

—

0.6

—

(4034850)

1.00

0.00

10.5

8.9

—

(44806071)

0.00

0.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1002224) Polysomnography panel

0.89

0.00

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

0.00

0.0

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

3.0

—

(40768446) Kidney Pathology biopsy report

0.00

0.0

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.0

9.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.0

4.8

—

1.3

—

(3024932) HLA-DR beta [Type]

0.00

0.0

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

(44806420)

0.00

0.0

1.6

—

(3008898) HLA-B27 [Presence]

0.96

0.00

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.0

11.8

—

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

0.00

0.0

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.00

0.0

8.2

—

24.7

—

(4015189)

0.00

0.0

4.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.0

1.2

—

136.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

0.00

0.0

1.2

—

70.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.0

1.0

—

7.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

2.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.91

0.00

3.2

2.9

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

7.0

—

208.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.0

10.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.1

—

148.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

0.93

0.00

1.7

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.91

0.00

1.4

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

1.3

—

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.00

0.0

1.2

—

4.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

27.2

—

(3042733) HLA Ab [Presence] in Serum

0.00

0.0

2.4

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

5.4

—

49.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_BRAIN_INFRATENT and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_BRAIN_INFRATENT	1.861 [1.47, 2.35]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.201

During the follow-up period (1.1.1998 — 31.12.2019), 125 out of 692 females with CD2_BENIGN_BRAIN_INFRATENT died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_BRAIN_INFRATENT	2.417 [1.8, 3.24]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.089

During the follow-up period (1.1.1998 — 31.12.2019), 122 out of 603 males with CD2_BENIGN_BRAIN_INFRATENT died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_BRAIN_INFRATENT.

N-year risk	Females	Males
1	0.215%	0.496%
5	1.161%	3.052%
10	2.919%	7.476%
15	5.319%	14.591%
20	9.131%	24.239%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_BRAIN_INFRATENT – Benign neoplasm: Brain, infratentorial

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Brain, infratentorial

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints